Skip to main content

Table 2 1H chemical shifts (in ppm) of the Ga3+-CP04 and Lu3+-CP04 complexes

From: Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor

Complex Amino acid NH Other H
Ga3+-CP04 D-Glu1 8.64 4.21 1.90, 2.27
Lu3+-CP04 8.66 4.09 1.99, 2.36
Ga3+-CP04 D-Glu2 8.62 4.26 1.90, 2.27
Lu3+-CP04 8.55 4.25 1.91, 2.02, 2.34
Ga3+-CP04 D-Glu3 8.28 4.24 1.88, 1.96, 2.25
Lu3+-CP04 8.29 4.26 1.95, 2.00, 2.31
Ga3+-CP04 D-Glu4 8.28 4.24 1.88, 1.96, 2.25
Lu3+-CP04 8.29 4.26 1.95, 2.00, 2.31
Ga3+-CP04 D-Glu5 8.33 4.22 1.93, 2.29
Lu3+-CP04 8.25 4.18 1.95, 2.30
Ga3+-CP04 D-Glu6 8.33 4.22 1.93, 2.29
Lu3+-CP04 8.25 4.18 1.95, 2.30
Ga3+-CP04 Ala7 8.30 4.11 1.18
Lu3+-CP04 8.30 4.09 1.18
Ga3+-CP04 Tyr8 7.96 4.37 2.89, 2.95, 6.79, 7.07
Lu3+-CP04 7.96 4.39 2.85, 2.94, 6.80, 7.08
Ga3+-CP04 Gly9 8.10 3.82  
Lu3+-CP04 8.08 3.83  
Ga3+-CP04 Trp10 7.74 4.59 3.24, 7.17, 7.20, 7.53, 10.10 (NH)
Lu3+-CP04 7.74 4.63 3.24, 7.10, 7.21, 7.54, 10.09 (NH)
Ga3+-CP04 Met11 7.76 4.15 2.09, 1.66
Lu3+-CP04 7.76 4.14 2.06, 1.67
Ga3+-CP04 Asp12 7.92 4.42 2.43, 2.58
Lu3+-CP04 7.91 4.42 2.46, 2.62
Ga3+-CP04 Phe13 8.05 4.49 2.95, 3.19, 7.15, 7.43
Lu3+-CP04 8.02 4.51 2.94, 3.17, 7.11, 7.44